On November 23, the Food and Drug Administration (TFDA) of the Ministry of Health and Welfare, Republic of China, announced that Fu Yuan Chemical & Pharmaceutical Co., Ltd. initiated a voluntary recall of its pharmaceutical product “WEIL TABLET 300MG “F.Y."" after the manufacturer confirmed a printing error on the specified batch.

Basic Information of Recalled Medication

  • Product Name: WEIL TABLET 300MG “F.Y.” (福元胃乳錠300毫克)
  • Indications: Relief of stomach discomfort or heartburn, or hyperacidity associated with diagnosed gastric and duodenal ulcers, gastritis, and esophagitis.
  • Active Ingredient: ALUMINUM HYDROXIDE DRIED GEL
  • License Number: DOH-MD-No. 042942
  • Batch Number: WEL717
  • License Holder: Fu Yuan Chemical & Pharmaceutical Co., Ltd.

Recall Details

  • Recall Classification: Class II[i]
  • Official Dispatch No.: FDA-Yao-Zi No. 1061410496 (TFDA Medicinal Products Division)
  • Dispatch Date: November 13, 2017
  • Announcement Date: November 23, 2017
  • Reason for Recall: Following a notification of defective drug product, a printing error on the specified batch was confirmed, and the manufacturer voluntarily initiated a recall after risk evaluation.
Further Reading
  1. Introduction to the TFDA Drug Recall Classification System and Disposal Measures
✦ Independent Journalism · Reader Support ✦

Support Independent Perspectives & In-Depth Insights

Every thoughtful analysis and candid critique comes from our dedication to truth and quality. We choose not to follow sensational algorithms or clickbait headlines.

Sustaining independent research requires reader support. Make a one-time or monthly contribution, securely processed by Google.

Payments secured by Google · Manage or cancel anytime in your Google Account